|
|
angiogenesis
|
GO:0001525 |
201 |
0.239
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.150
|
|
|
|
sprouting angiogenesis
|
GO:0002040 |
26 |
0.136
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.133
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.132
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.130
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.120
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.120
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.113
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.112
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.110
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.108
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.105
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.105
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.102
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.100
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.100
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.093
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.093
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.090
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.087
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.087
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.087
|
|
|
|
mesenchymal cell differentiation
|
GO:0048762 |
107 |
0.086
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.085
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.085
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.083
|
|
|
|
vesicle localization
|
GO:0051648 |
86 |
0.081
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.080
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.080
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.079
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.079
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.077
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.077
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.077
|
|
|
|
establishment of synaptic vesicle localization
|
GO:0097480 |
57 |
0.077
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.076
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.076
|
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.076
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.076
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.075
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.073
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.073
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.073
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.073
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.072
|
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.072
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.071
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.070
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.070
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.070
|
|
|
|
neurotransmitter transport
|
GO:0006836 |
76 |
0.069
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.068
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.068
|
|
|
|
synaptic vesicle localization
|
GO:0097479 |
59 |
0.067
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.066
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.065
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.065
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.065
|
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.063
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.061
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.061
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.061
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.060
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.060
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.060
|
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.060
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.059
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.058
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.058
|
|
|
|
synaptic vesicle transport
|
GO:0048489 |
57 |
0.057
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.057
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.056
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.056
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.056
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.056
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.055
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.055
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.055
|
|
|
|
renal system development
|
GO:0072001 |
225 |
0.053
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.053
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.053
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.053
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.052
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.052
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.051
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.051
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.051
|
|
|
|
endothelial cell migration
|
GO:0043542 |
44 |
0.051
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.051
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.050
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.050
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.050
|
Mouse |
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.049
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.049
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.046
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.045
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.045
|
|
|
|
sympathetic neuron projection extension
|
GO:0097490 |
4 |
0.044
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.044
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.043
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.043
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.042
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.042
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.042
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.041
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.041
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.041
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.041
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.040
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.040
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.040
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.040
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.040
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.040
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.040
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.039
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.039
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.039
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.038
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.038
|
|
|
|
regulation of vascular endothelial growth factor receptor signaling pathway
|
GO:0030947 |
14 |
0.038
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.038
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.038
|
|
|
|
trunk neural crest cell migration
|
GO:0036484 |
4 |
0.037
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.037
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.037
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.037
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.037
|
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.036
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.036
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.035
|
|
|
|
heart trabecula morphogenesis
|
GO:0061384 |
26 |
0.035
|
|
|
|
regulation of epithelial to mesenchymal transition
|
GO:0010717 |
22 |
0.035
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.035
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.035
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.035
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
97 |
0.035
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.035
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.035
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.034
|
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.034
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.033
|
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.033
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.033
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.033
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.033
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.032
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.032
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.032
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.032
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.032
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.032
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.032
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.032
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.032
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.032
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.032
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.031
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.031
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.031
|
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation
|
GO:2000721 |
2 |
0.031
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.031
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.031
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.031
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.030
|
|
|
|
somite development
|
GO:0061053 |
81 |
0.030
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.030
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.030
|
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.029
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.029
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
126 |
0.029
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.029
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.029
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.029
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.029
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.029
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.028
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.028
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.028
|
|
|
|
vascular endothelial growth factor receptor signaling pathway
|
GO:0048010 |
24 |
0.028
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.028
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.028
|
|
|
|
aortic valve morphogenesis
|
GO:0003180 |
4 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.028
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.028
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.027
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.027
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.027
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.027
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.027
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.027
|
|
|
|
positive regulation of muscle cell differentiation
|
GO:0051149 |
39 |
0.027
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.027
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.026
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.026
|
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.026
|
|
|
|
facioacoustic ganglion development
|
GO:1903375 |
3 |
0.026
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.026
|
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.026
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.026
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.026
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.026
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.026
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.026
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.026
|
|
|
|
rac protein signal transduction
|
GO:0016601 |
13 |
0.025
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.025
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.025
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.025
|
|
|
|
sympathetic neuron projection guidance
|
GO:0097491 |
4 |
0.025
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.025
|
|
|
|
syncytiotrophoblast cell differentiation involved in labyrinthine layer development
|
GO:0060715 |
2 |
0.025
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.025
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.025
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.025
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.025
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.025
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.024
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.024
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.024
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.024
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.024
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.024
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.024
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.024
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.024
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.024
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.023
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.023
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.023
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.023
|
|
|
|
regulation of cell migration involved in sprouting angiogenesis
|
GO:0090049 |
4 |
0.023
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.023
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.023
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.023
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.023
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.023
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.023
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.022
|
|
|
|
regulation of stem cell proliferation
|
GO:0072091 |
78 |
0.022
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.022
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.022
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.022
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.022
|
|
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.022
|
|
|
|
mesoderm development
|
GO:0007498 |
100 |
0.022
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.022
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.022
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.022
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.022
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.022
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.022
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.022
|
|
|
|
regulation of tight junction assembly
|
GO:2000810 |
2 |
0.022
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.022
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
43 |
0.021
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.021
|
|
|
|
regulation of neural precursor cell proliferation
|
GO:2000177 |
70 |
0.021
|
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.021
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.021
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.021
|
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.021
|
|
|
|
synaptic vesicle exocytosis
|
GO:0016079 |
26 |
0.021
|
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.021
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.021
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.021
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.021
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.021
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.021
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.020
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.020
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.020
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.020
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.020
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.020
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.020
|
|
|
|
negative regulation of canonical wnt signaling pathway
|
GO:0090090 |
51 |
0.020
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.020
|
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.020
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.020
|
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.020
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.020
|
|
|
|
negative regulation of neuron differentiation
|
GO:0045665 |
101 |
0.020
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.020
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.019
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.019
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.019
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.019
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.019
|
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.019
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.019
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.019
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.019
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.019
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.019
|
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.018
|
Mouse |
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.018
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.018
|
|
|
|
plasma membrane repair
|
GO:0001778 |
7 |
0.018
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.018
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.018
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.018
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.018
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.018
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.018
|
|
|
|
nephron epithelium development
|
GO:0072009 |
92 |
0.017
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.017
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.017
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.017
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.017
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
73 |
0.017
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.017
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.017
|
|
|
|
stem cell proliferation
|
GO:0072089 |
117 |
0.017
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.017
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.017
|
|
|
|
trunk segmentation
|
GO:0035290 |
4 |
0.017
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.017
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.017
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.017
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.017
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.017
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.017
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.017
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.017
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.016
|
|
|
|
gonadotrophin releasing hormone neuronal migration to the hypothalamus
|
GO:0021828 |
3 |
0.016
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.016
|
|
|
|
regulation of extent of cell growth
|
GO:0061387 |
52 |
0.016
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.016
|
Mouse |
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.016
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.016
|
Mouse |
|
|
lens development in camera type eye
|
GO:0002088 |
62 |
0.016
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.016
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.016
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.016
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.016
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.016
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.016
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.016
|
|
|
|
hypothalamic tangential migration using cell axon interactions
|
GO:0021856 |
3 |
0.016
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.016
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.016
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.016
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.016
|
|
|
|
regulation of innate immune response
|
GO:0045088 |
91 |
0.016
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.016
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.016
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.016
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
|
transcription from rna polymerase i promoter
|
GO:0006360 |
13 |
0.016
|
|
|
|
negative regulation of catenin import into nucleus
|
GO:0035414 |
2 |
0.016
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
26 |
0.016
|
|
|
|
regulation of t cell proliferation
|
GO:0042129 |
92 |
0.015
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.015
|
|
|
|
cell migration involved in endocardial cushion formation
|
GO:0003273 |
3 |
0.015
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.015
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.015
|
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.015
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.015
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.015
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.015
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.015
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.015
|
|
|
|
cell cell junction assembly
|
GO:0007043 |
27 |
0.015
|
|
|
|
regulation of organ growth
|
GO:0046620 |
61 |
0.015
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.015
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.015
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.015
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.015
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.015
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.015
|
|
|
|
somitogenesis
|
GO:0001756 |
69 |
0.015
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.015
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.015
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.015
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.015
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.015
|
|
|
|
pseudopodium organization
|
GO:0031268 |
2 |
0.015
|
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.014
|
|
|
|
trabecula morphogenesis
|
GO:0061383 |
40 |
0.014
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.014
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.014
|
|
|
|
hypothalamus gonadotrophin releasing hormone neuron development
|
GO:0021888 |
4 |
0.014
|
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.014
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.014
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.014
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.014
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.014
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.014
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.014
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.014
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.014
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.014
|
|
|
|
response to heat
|
GO:0009408 |
27 |
0.014
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.014
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.014
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.014
|
|
|
|
sympathetic ganglion development
|
GO:0061549 |
9 |
0.014
|
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.014
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.014
|
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.014
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.014
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.014
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.014
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.013
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.013
|
|
|
|
regulation of muscle contraction
|
GO:0006937 |
49 |
0.013
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.013
|
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.013
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.013
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.013
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.013
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.013
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.013
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.013
|
|
|
|
negative regulation of execution phase of apoptosis
|
GO:1900118 |
4 |
0.013
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.013
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.013
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.013
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.013
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.013
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.013
|
|
|
|
formation of organ boundary
|
GO:0010160 |
1 |
0.013
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.013
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.013
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.013
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.013
|
|
|
|
developmental cell growth
|
GO:0048588 |
84 |
0.013
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.013
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.013
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.013
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.013
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.013
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.013
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.013
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.013
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.012
|
|
|
|
regulation of axon extension
|
GO:0030516 |
43 |
0.012
|
|
|
|
negative regulation of blood vessel endothelial cell migration
|
GO:0043537 |
3 |
0.012
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.012
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.012
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.012
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.012
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.012
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.012
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.012
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.012
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.012
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.012
|
|
|
|
muscular septum morphogenesis
|
GO:0003150 |
4 |
0.012
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.012
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.012
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.012
|
|
|
|
commissural neuron axon guidance
|
GO:0071679 |
8 |
0.012
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.012
|
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.012
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.012
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
61 |
0.012
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.012
|
|
|
|
heart trabecula formation
|
GO:0060347 |
14 |
0.012
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.012
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.012
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.012
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.012
|
|
|
|
positive regulation of muscle tissue development
|
GO:1901863 |
32 |
0.012
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.012
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.012
|
|
|
|
cardiac chamber development
|
GO:0003205 |
108 |
0.012
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.012
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.012
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.012
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.012
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.012
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.012
|
Mouse |
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.012
|
|
|
|
cell cell adhesion via plasma membrane adhesion molecules
|
GO:0098742 |
40 |
0.012
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.012
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.012
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
147 |
0.012
|
|
|
|
negative regulation of organelle organization
|
GO:0010639 |
90 |
0.012
|
|
